KEY TRENDS • Section 105 of the Right to Fair Compensation and Transparency in the Land Acquisition, Rehabilitation and Resettlement Act, 2013, which provides for excluding 13 Central legislation, including Land Acquisition (Mines) Act 1885, Atomic Energy Act, 1962, Railway Act 1989, National Highways Act 1956 and Metro Railways (Construction of Works) Act, 1978, from its purview, has been amended for payment of compensation with rigours $ • The amendments have now...
More »SEARCH RESULT
Total Matching Records found : 115
Patent concerns by CP Chandrasekhar
The discussion paper on compulsory licensing of patents will have achieved its purpose if it can lead to a proactive policy in the area of drugs and health. IN a proactive move to ensure a fair balance between protection of intellectual property rights and protection of the public interest, the Department of Industrial Policy and Promotion (DIPP) of the Ministry of Commerce and Industry has chosen to put out a discussion...
More »Trade Talks with EU Put Drug Manufacturers on Edge by Keya Acharya
Their ongoing negotiations remain shrouded in secrecy, but there are already reports that India and the European Union (EU) will have a free-trade agreement ready by the end of August, and that they will be putting signatures to it before the end of 2010. Yet it is a potential development that is causing more nervous chatter than joyous jitters here in India, where drug manufacturers in particular have raised concerns over...
More »Legally bound
New Delhi has done well to declare its intention to play a proactive role at the forthcoming Convention on Biological Diversity (CBD) at Nagoya (Japan) in October for thrashing out a legally binding pact on access to and benefit-sharing of biological resources. Being one of the world’s 12 mega biodiversity centres, India has substantial stakes in both preserving the biodiversity and capitalising on its commercial potential. Though the CBD, signed...
More »Will India-EU deal make drugs dearer? by Rema Nagarajan
Is the Indian government bargaining away the rights of millions across the world to essential drugs supplied by India, hailed as the pharmacy of the developing world, in the name of free trade with the European Union (EU)? That's a fear being expressed by civil society groups in the developing world. Commerce minister Anand Sharma vehemently denies such a possibility, claiming that the free trade agreement (FTA) under negotiation with...
More »
